Why physicians join our endocrinology community
Sermo’s endocrinology physician network provides practicing endocrinologists with a secure, peer-driven platform to discuss advances in metabolic and hormonal disorders, evolving treatment guidelines, and emerging therapies. Whether you focus on diabetes, thyroid disease, obesity medicine, osteoporosis, adrenal disorders, or pituitary conditions, Sermo connects you to peers facing similar challenges—from interpreting complex lab results to managing lifelong, chronic conditions and rapidly changing therapeutic options.
Earn money sharing your endocrinology expertise
Learn why surveys are worth it for endocrinologists and tackle topics such as:
- Surveys on GLP-1 receptor agonists and insulin therapies
- Opinion polls on diabetes technology and CGM adoption
- Research studies on obesity, metabolic syndrome, and bone health management

Access endocrinology drug insights from peers
Get practical, peer-reviewed information on endocrine treatments:
- Detailed safety profiles of insulin, GLP-1 therapies, and hormone replacement treatments
- Comparative efficacy assessments
- Real-world tolerability experiences
- FDA approval timelines for new endocrine drugs and practical use cases

Learn from endocrinology articles and case studies
Discover strategies and real-world advice based on insights from physicians on Sermo.
- Managing complex type 2 diabetes cases
- Communicating lifelong diagnoses like hypothyroidism or osteoporosis
- Barriers to adherence with injectable and oral therapies
- Advances in obesity medicine and metabolic care

Hear from fellow physician peers
I read case presentations and learn a lot from some of them. Commenting on topics of interest and participating in surveys are my favorites.
It has enlightened me about my practice decisions, and supported me to get quick reliable help in solving mystery cases.
My favorite part of Sermo is the hallway consultations, where we can exchange opinions and perspectives on different clinical cases with colleagues from all over the world.
Frequently asked questions
Sermo’s endocrinology community regularly shares updates and discussions around FDA approvals, trial outcomes, and real-world experiences with new endocrine drugs, biologics, and medical devices.
Yes. Our drug ratings feature allows endocrinologists to review and compare medications across efficacy, safety, and tolerability—based on real-world experiences.
Absolutely. Sermo members frequently share information related to clinical trial eligibility for diabetes, obesity, osteoporosis, thyroid disease, and emerging endocrine therapies, as well as recruitment challenges.
Yes. Whether you practice in a hospital setting, outpatient clinic, or specialty center, Sermo provides a space to share your expertise and learn from others.
You’ll find case studies ranging from insulin titration challenges and endocrine workups to long-term metabolic disease management.
Yes. Many discussions focus on coding, reimbursement for diabetes technologies, injectable therapies, and the business side of running an endocrinology practice.
Sermo enables real-time collaboration. Post a case anonymously and receive input within hours—helping you make confident decisions when time and clarity matter most.
Sermo is designed to complement—not replace—professional societies and formal networks. It gives physicians a place for real-time peer discussion, specialty-specific insights, and opportunities to contribute to paid research, all within a physician-only community that fits easily into day-to-day practice.
If you’d like to see how Sermo compares with other physician networks, explore how we differ from Doximity or M3 Global.
Start your endocrinology journey on Sermo
Become part of a dynamic endocrinology physician network of over 29,000 members dedicated to advancing metabolic and hormonal care through peer collaboration and expert insights.



